83 related articles for article (PubMed ID: 7850397)
1. An exploratory evaluation of ECT in haloperidol-treated DSM-IIIR schizophreniform disorder.
Sarkar P; Andrade C; Kapur B; Das P; Sivaramakrishna Y; Harihar C; Pandey A; Anand A; Dharmendra MS
Convuls Ther; 1994 Dec; 10(4):271-8. PubMed ID: 7850397
[TBL] [Abstract][Full Text] [Related]
2. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
3. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
4. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
[TBL] [Abstract][Full Text] [Related]
5. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
Ikeji OC; Ohaeri JU; Osahon RO; Agidee RO
East Afr Med J; 1999 Nov; 76(11):644-50. PubMed ID: 10734527
[TBL] [Abstract][Full Text] [Related]
6. DSM melancholic features are unreliable predictors of ECT response: a CORE publication.
Fink M; Rush AJ; Knapp R; Rasmussen K; Mueller M; Rummans TA; O'Connor K; Husain M; Biggs M; Bailine S; Kellner CH;
J ECT; 2007 Sep; 23(3):139-46. PubMed ID: 17804986
[TBL] [Abstract][Full Text] [Related]
7. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
Nisijima K; Ishiguro T
J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
[TBL] [Abstract][Full Text] [Related]
8. Effects of twice- versus thrice-weekly electroconvulsive therapy in schizophrenia.
Chanpattana W; Chakrabhand ML; Kitaroonchai W; Choovanichvong S; Prasertsuk Y
J Med Assoc Thai; 1999 May; 82(5):477-83. PubMed ID: 10443097
[TBL] [Abstract][Full Text] [Related]
9. Electroconvulsive therapy in adolescents: similarities to and differences from adults.
Bloch Y; Levcovitch Y; Bloch AM; Mendlovic S; Ratzoni G
J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1332-6. PubMed ID: 11699808
[TBL] [Abstract][Full Text] [Related]
10. The use of the stabilization period in electroconvulsive therapy research in schizophrenia: II. Implementation.
Chanpattana W; Chakrabhand ML; Kirdcharoen N; Tuntirungsee Y; Techakasem P; Prasertsuk Y
J Med Assoc Thai; 1999 Jun; 82(6):558-68. PubMed ID: 10443077
[TBL] [Abstract][Full Text] [Related]
11. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response.
Sienaert P; Vansteelandt K; Demyttenaere K; Peuskens J
Bipolar Disord; 2009 Jun; 11(4):418-24. PubMed ID: 19500095
[TBL] [Abstract][Full Text] [Related]
12. Continuation ECT in treatment-resistant schizophrenia: a controlled study.
Chanpattana W; Chakrabhand ML; Sackeim HA; Kitaroonchai W; Kongsakon R; Techakasem P; Buppanharun W; Tuntirungsee Y; Kirdcharoen N
J ECT; 1999 Sep; 15(3):178-92. PubMed ID: 10492856
[TBL] [Abstract][Full Text] [Related]
13. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
[TBL] [Abstract][Full Text] [Related]
14. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT.
Flint AJ; Rifat SL
Int J Geriatr Psychiatry; 1998 Jan; 13(1):23-8. PubMed ID: 9489577
[TBL] [Abstract][Full Text] [Related]
15. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
[TBL] [Abstract][Full Text] [Related]
16. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
[TBL] [Abstract][Full Text] [Related]
17. A Double-Blind Comparison of Sinusoidal Wave and Brief-Pulse Electroconvulsive Therapy in Endogenous Depression.
Andrade C; Gangadhar BN; Subbakrishna DK; Channabasavanna SM; Pradhan N
Convuls Ther; 1988; 4(4):297-305. PubMed ID: 11940979
[TBL] [Abstract][Full Text] [Related]
18. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
19. Moderate hyperventilation prolongs electroencephalogram seizure duration of the first electroconvulsive therapy.
Sawayama E; Takahashi M; Inoue A; Nakajima K; Kano A; Sawayama T; Okutomi T; Miyaoka H
J ECT; 2008 Sep; 24(3):195-8. PubMed ID: 18772703
[TBL] [Abstract][Full Text] [Related]
20. Double-blind randomized controlled study comparing short-term efficacy of bifrontal and bitemporal electroconvulsive therapy in acute mania.
Hiremani RM; Thirthalli J; Tharayil BS; Gangadhar BN
Bipolar Disord; 2008 Sep; 10(6):701-7. PubMed ID: 18837864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
